Varese, Italy

Luigi Petrucciani

This inventor holds 1 USPTO granted patent. Top assignee: Clariant Life Science Molecules (Italy) S.p.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luigi Petrucciani. Retrieved from https://idiyas.com/inventor/luigi-petrucciani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luigi Petrucciani: Innovator in Antiviral Chemistry

Introduction

Luigi Petrucciani is a notable inventor based in Varese, Italy. He has made significant contributions to the field of antiviral chemistry, particularly through his innovative processes. His work has implications for the development of important antiviral medications.

Latest Patents

Luigi Petrucciani holds a patent for a process for preparing 5′-acetylstavudine. This compound serves as an intermediate in the synthesis of 2′,3′-didehydro-3′-deoxythymidine, commonly known as stavudine (D4T). Stavudine is recognized for its antiviral properties, making Petrucciani's invention particularly valuable in the pharmaceutical industry.

Career Highlights

Petrucciani is associated with Clariant Life Science Molecules S.p.A., where he applies his expertise in chemical processes. His work at Clariant has allowed him to focus on developing innovative solutions in life sciences, contributing to advancements in antiviral treatments.

Collaborations

Luigi Petrucciani has collaborated with notable colleagues such as Giorgio Bertolini and Marco Frigerio. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical processes.

Conclusion

Luigi Petrucciani's contributions to antiviral chemistry through his patent and work at Clariant Life Science Molecules highlight his role as an important inventor in the field. His innovative processes continue to impact the development of antiviral medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…